ENSC Ensysce Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ENSC

Price (delayed)

$0.56

Market cap

$4.1M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.69

Enterprise value

$3.84M

Highlights
ENSC's net income has surged by 56% year-on-year and by 16% since the previous quarter
Ensysce Biosciences's debt has soared by 142% from the previous quarter but it has plunged by 81% YoY
The equity has plunged by 122% from the previous quarter but it has soared by 91% YoY
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of ENSC
Market
Shares outstanding
7.33M
Market cap
$4.1M
Enterprise value
$3.84M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$10.26M
EBITDA
-$10.26M
Free cash flow
-$10.78M
Per share
EPS
-$4.69
Free cash flow per share
-$4.76
Book value per share
-$0.1
Revenue per share
$0
TBVPS
$1.2
Balance sheet
Total assets
$2.71M
Total liabilities
$3.36M
Debt
$854,697
Equity
-$322,858
Working capital
-$1.04M
Liquidity
Debt to equity
-2.65
Current ratio
0.69
Quick ratio
0.37
Net debt/EBITDA
0.03
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-262.4%
Return on equity
-780.2%
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENSC stock price

How has the Ensysce Biosciences stock price performed over time
Intraday
-1.75%
1 week
-6.67%
1 month
-30.36%
1 year
-84.95%
YTD
-47.17%
QTD
-29.13%

Financial performance

How have Ensysce Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.72M
Net income
-$10.61M
Gross margin
N/A
Net margin
N/A
ENSC's net income has surged by 56% year-on-year and by 16% since the previous quarter
Ensysce Biosciences's operating income has surged by 56% YoY and by 22% QoQ

Growth

What is Ensysce Biosciences's growth rate over time

Valuation

What is Ensysce Biosciences stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 97% YoY but it has shrunk by 91% QoQ
The equity has plunged by 122% from the previous quarter but it has soared by 91% YoY

Efficiency

How efficient is Ensysce Biosciences business performance
ENSC's return on equity has surged by 68% since the previous quarter
The company's return on assets rose by 10% YoY

Dividends

What is ENSC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENSC.

Financial health

How did Ensysce Biosciences financials performed over time
Ensysce Biosciences's total assets is 19% lower than its total liabilities
The total liabilities has plunged by 66% YoY but it has soared by 63% from the previous quarter
Ensysce Biosciences's total assets has shrunk by 54% YoY and by 16% QoQ
Ensysce Biosciences's debt has soared by 142% from the previous quarter but it has plunged by 81% YoY
ENSC's debt to equity has shrunk by 123% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.